Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC‐driven hepatocellular carcinoma
Abstract Deregulation of MYC is among the most frequent oncogenic drivers in hepatocellular carcinoma (HCC). Unfortunately, the clinical success of MYC‐targeted therapies is limited. Synthetic lethality offers an alternative therapeutic strategy by leveraging on vulnerabilities in tumors with MYC de...
Saved in:
Main Authors: | Dexter Kai Hao Thng (Author), Tan Boon Toh (Author), Paolo Pigini (Author), Lissa Hooi (Author), Yock Young Dan (Author), Pierce Kah‐Hoe Chow (Author), Glenn Kunnath Bonney (Author), Masturah Bte Mohd Abdul Rashid (Author), Ernesto Guccione (Author), Dave Keng Boon Wee (Author), Edward Kai‐Hua Chow (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis
by: Doudou Jing, et al.
Published: (2023) -
Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
by: Li H, et al.
Published: (2022) -
Functions and inhibitors of CHK1 in cancer therapy
by: Kailong Jiang, et al.
Published: (2024) -
circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex
by: Fei Xie, et al.
Published: (2020) -
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
by: Kunlong Zhang, et al.
Published: (2022)